Global Recombinant Plasma Protein Therapeutics Industry Research Report 2020, Forecast to 2025

June 2020 | 101 pages | ID: G5121DC114F0EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Recombinant Plasma Protein Therapeutics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Recombinant Plasma Protein Therapeutics is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Recombinant Plasma Protein Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Recombinant Plasma Protein Therapeutics by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Recombinant Plasma Protein Therapeutics market are discussed.

The market is segmented by types:

• Recombinant Coagulation Factors
• Human C1 Esterase Inhibitor

It can be also divided by applications:

• Hemophilia A
• Hemophilia B
• Von Willebrand Disease

And this report covers the historical situation, present status and the future prospects of the global Recombinant Plasma Protein Therapeutics market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• CSL Limited
• Pharming Group
• Novo Nordisk A/S
• Takeda
• Aptevo Therapeutics
• Octapharma
• Bioverativ Therapeutics
• Pfizer

Report Includes:

• xx data tables and xx additional tables
• An overview of global Recombinant Plasma Protein Therapeutics market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Recombinant Plasma Protein Therapeutics market
• Profiles of major players in the industry, including%li% CSL Limited, Pharming Group, Novo Nordisk A/S, Takeda, Aptevo Therapeutics.....

Research objectives

• To study and analyze the global Recombinant Plasma Protein Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Recombinant Plasma Protein Therapeutics market by identifying its various subsegments.
• Focuses on the key global Recombinant Plasma Protein Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Recombinant Plasma Protein Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Recombinant Plasma Protein Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Recombinant Plasma Protein Therapeutics Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Recombinant Plasma Protein Therapeutics Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 RECOMBINANT PLASMA PROTEIN THERAPEUTICS INDUSTRY OVERVIEW

2.1 Global Recombinant Plasma Protein Therapeutics Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Recombinant Plasma Protein Therapeutics Global Import Market Analysis
  2.1.2 Recombinant Plasma Protein Therapeutics Global Export Market Analysis
  2.1.3 Recombinant Plasma Protein Therapeutics Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Recombinant Coagulation Factors
  2.2.2 Human C1 Esterase Inhibitor
2.3 Market Analysis by Application
  2.3.1 Hemophilia A
  2.3.2 Hemophilia B
  2.3.3 Von Willebrand Disease
2.4 Global Recombinant Plasma Protein Therapeutics Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Recombinant Plasma Protein Therapeutics Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Recombinant Plasma Protein Therapeutics Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Recombinant Plasma Protein Therapeutics Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Recombinant Plasma Protein Therapeutics Manufacturer Market Share
  2.4.5 Top 10 Recombinant Plasma Protein Therapeutics Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Recombinant Plasma Protein Therapeutics Market
  2.4.7 Key Manufacturers Recombinant Plasma Protein Therapeutics Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Recombinant Plasma Protein Therapeutics Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Recombinant Plasma Protein Therapeutics Industry Impact
  2.7.1 How the Covid-19 is Affecting the Recombinant Plasma Protein Therapeutics Industry
  2.7.2 Recombinant Plasma Protein Therapeutics Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Recombinant Plasma Protein Therapeutics Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Recombinant Plasma Protein Therapeutics Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL RECOMBINANT PLASMA PROTEIN THERAPEUTICS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Recombinant Plasma Protein Therapeutics Sales Market Share by Region
4.2 Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2015-2019)
4.3 Global Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Recombinant Plasma Protein Therapeutics Market Size Detail
  4.4.1 North America Recombinant Plasma Protein Therapeutics Sales Growth Rate (2015-2020)
  4.4.2 North America Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Recombinant Plasma Protein Therapeutics Market Size Detail
  4.5.1 Europe Recombinant Plasma Protein Therapeutics Sales Growth Rate (2015-2020)
  4.5.2 Europe Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Recombinant Plasma Protein Therapeutics Market Size Detail
  4.6.1 Japan Recombinant Plasma Protein Therapeutics Sales Growth Rate (2015-2020)
  4.6.2 Japan Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Recombinant Plasma Protein Therapeutics Market Size Detail
  4.7.1 China Recombinant Plasma Protein Therapeutics Sales Growth Rate (2015-2020)
  4.7.2 China Recombinant Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL RECOMBINANT PLASMA PROTEIN THERAPEUTICS MARKET SEGMENT BY TYPE

5.1 Global Recombinant Plasma Protein Therapeutics Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Recombinant Plasma Protein Therapeutics Sales and Market Share by Type (2015-2020)
  5.1.2 Global Recombinant Plasma Protein Therapeutics Revenue and Market Share by Type (2015-2020)
5.2 Recombinant Coagulation Factors Sales Growth Rate and Price
  5.2.1 Global Recombinant Coagulation Factors Sales Growth Rate (2015-2020)
  5.2.2 Global Recombinant Coagulation Factors Price (2015-2020)
5.3 Human C1 Esterase Inhibitor Sales Growth Rate and Price
  5.3.1 Global Human C1 Esterase Inhibitor Sales Growth Rate (2015-2020)
  5.3.2 Global Human C1 Esterase Inhibitor Price (2015-2020)

6 GLOBAL RECOMBINANT PLASMA PROTEIN THERAPEUTICS MARKET SEGMENT BY APPLICATION

6.1 Global Recombinant Plasma Protein TherapeuticsSales Market Share by Application (2015-2020)
6.2 Hemophilia A Sales Growth Rate (2015-2020)
6.3 Hemophilia B Sales Growth Rate (2015-2020)
6.4 Von Willebrand Disease Sales Growth Rate (2015-2020)

7 GLOBAL RECOMBINANT PLASMA PROTEIN THERAPEUTICS MARKET FORECAST

7.1 Global Recombinant Plasma Protein Therapeutics Sales, Revenue Forecast
  7.1.1 Global Recombinant Plasma Protein Therapeutics Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Recombinant Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Recombinant Plasma Protein Therapeutics Price and Trend Forecast (2020-2025)
7.2 Global Recombinant Plasma Protein Therapeutics Sales Forecast by Region (2020-2025)
  7.2.1 North America Recombinant Plasma Protein Therapeutics Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Recombinant Plasma Protein Therapeutics Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Recombinant Plasma Protein Therapeutics Production, Revenue Forecast (2020-2025)
  7.2.4 China Recombinant Plasma Protein Therapeutics Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF RECOMBINANT PLASMA PROTEIN THERAPEUTICS INDUSTRY KEY MANUFACTURERS

8.1 CSL Limited
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 CSL Limited Recombinant Plasma Protein Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 CSL Limited News
8.2 Pharming Group
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Pharming Group Recombinant Plasma Protein Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Pharming Group News
8.3 Novo Nordisk A/S
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Novo Nordisk A/S News
8.4 Takeda
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Takeda Recombinant Plasma Protein Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Takeda News
8.5 Aptevo Therapeutics
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Aptevo Therapeutics News
8.6 Octapharma
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Octapharma Recombinant Plasma Protein Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Octapharma News
8.7 Bioverativ Therapeutics
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Bioverativ Therapeutics News
8.8 Pfizer
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Pfizer Recombinant Plasma Protein Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Pfizer News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Recombinant Plasma Protein Therapeutics Picture
Figure Research Programs/Design for This Report
Figure Global Recombinant Plasma Protein Therapeutics Market by Regions (2019)
Table Global Market Recombinant Plasma Protein Therapeutics Comparison by Regions (M USD) 2019-2025
Table Global Recombinant Plasma Protein Therapeutics Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Recombinant Plasma Protein Therapeutics by Type in 2019
Figure Recombinant Coagulation Factors Picture
Figure Human C1 Esterase Inhibitor Picture
Table Global Recombinant Plasma Protein Therapeutics Sales by Application (2019-2025)
Figure Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application in 2019
Figure Hemophilia A Picture
Figure Hemophilia B Picture
Figure Von Willebrand Disease Picture
Table Global Recombinant Plasma Protein Therapeutics Sales by Manufacturer (2018-2020)
Figure Global Recombinant Plasma Protein Therapeutics Sales Market Share by Manufacturer in 2019
Table Global Recombinant Plasma Protein Therapeutics Revenue by Manufacturer (2018-2020)
Figure Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Manufacturer in 2019
Table Global Recombinant Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Recombinant Plasma Protein Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Recombinant Plasma Protein Therapeutics Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Recombinant Plasma Protein Therapeutics Market
Table Key Manufacturers Recombinant Plasma Protein Therapeutics Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Plasma Protein Therapeutics
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Recombinant Plasma Protein Therapeutics Sales (K Units) by Region (2015-2020)
Table Global Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2015-2019)
Figure Global Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2015-2019)
Figure Global Recombinant Plasma Protein Therapeutics Sales Market Share by Region in 2018
Table Global Recombinant Plasma Protein Therapeutics Revenue (Million US$) by Region (2015-2020)
Table Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2015-2020)
Figure Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2015-2020)
Figure Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Region in 2019
Table Global Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Recombinant Plasma Protein Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table North America Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Recombinant Plasma Protein Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table Europe Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Recombinant Plasma Protein Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table Japan Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Recombinant Plasma Protein Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table China Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Recombinant Plasma Protein Therapeutics Sales by Type (2015-2020)
Table Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2015-2020)
Figure Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type in 2019
Table Global Recombinant Plasma Protein Therapeutics Revenue by Type (2015-2020)
Table Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Type (2015-2020)
Figure Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Type in 2019
Figure Global Recombinant Coagulation Factors Sales Growth Rate (2015-2020)
Figure Global Recombinant Coagulation Factors Price (2015-2020)
Figure Global Human C1 Esterase Inhibitor Sales Growth Rate (2015-2020)
Figure Global Human C1 Esterase Inhibitor Price (2015-2020)
Table Global Recombinant Plasma Protein Therapeutics Sales by Application (2015-2020)
Table Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2015-2020)
Figure Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application in 2019
Figure Global Hemophilia A Sales Growth Rate (2015-2020)
Figure Global Hemophilia B Sales Growth Rate (2015-2020)
Figure Global Von Willebrand Disease Sales Growth Rate (2015-2020)
Figure Global Recombinant Plasma Protein Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Recombinant Plasma Protein Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Recombinant Plasma Protein Therapeutics Price and Trend Forecast (2020-2025)
Table Global Recombinant Plasma Protein Therapeutics Sales (K Units) Forecast by Region (2020-2025)
Figure Global Recombinant Plasma Protein Therapeutics Production Market Share Forecast by Region (2020-2025)
Figure North America Recombinant Plasma Protein Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Recombinant Plasma Protein Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Recombinant Plasma Protein Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Recombinant Plasma Protein Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Recombinant Plasma Protein Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Recombinant Plasma Protein Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Recombinant Plasma Protein Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Recombinant Plasma Protein Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table CSL Limited Company Profile
Figure Recombinant Plasma Protein Therapeutics Product Picture and Specifications of CSL Limited
Table Recombinant Plasma Protein Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure CSL Limited Recombinant Plasma Protein Therapeutics Market Share (2018-2020)
Table CSL Limited Main Business
Table CSL Limited Recent Development
Table Pharming Group Company Profile
Figure Recombinant Plasma Protein Therapeutics Product Picture and Specifications of Pharming Group
Table Recombinant Plasma Protein Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pharming Group Recombinant Plasma Protein Therapeutics Market Share (2018-2020)
Table Pharming Group Main Business
Table Pharming Group Recent Development
Table Novo Nordisk A/S Company Profile
Figure Recombinant Plasma Protein Therapeutics Product Picture and Specifications of Novo Nordisk A/S
Table Recombinant Plasma Protein Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Market Share (2018-2020)
Table Novo Nordisk A/S Main Business
Table Novo Nordisk A/S Recent Development
Table Takeda Company Profile
Figure Recombinant Plasma Protein Therapeutics Product Picture and Specifications of Takeda
Table Recombinant Plasma Protein Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Takeda Recombinant Plasma Protein Therapeutics Market Share (2018-2020)
Table Takeda Main Business
Table Takeda Recent Development
Table Aptevo Therapeutics Company Profile
Figure Recombinant Plasma Protein Therapeutics Product Picture and Specifications of Aptevo Therapeutics
Table Recombinant Plasma Protein Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Market Share (2018-2020)
Table Aptevo Therapeutics Main Business
Table Aptevo Therapeutics Recent Development
Table Octapharma Company Profile
Figure Recombinant Plasma Protein Therapeutics Product Picture and Specifications of Octapharma
Table Recombinant Plasma Protein Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Octapharma Recombinant Plasma Protein Therapeutics Market Share (2018-2020)
Table Octapharma Main Business
Table Octapharma Recent Development
Table Bioverativ Therapeutics Company Profile
Figure Recombinant Plasma Protein Therapeutics Product Picture and Specifications of Bioverativ Therapeutics
Table Recombinant Plasma Protein Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Market Share (2018-2020)
Table Bioverativ Therapeutics Main Business
Table Bioverativ Therapeutics Recent Development
Table Pfizer Company Profile
Figure Recombinant Plasma Protein Therapeutics Product Picture and Specifications of Pfizer
Table Recombinant Plasma Protein Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Recombinant Plasma Protein Therapeutics Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table of Appendix